Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment-Reference-Cited by-同舟云学术

Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment

Published:2024-05-28 Issue:8 Volume:113 Page:1263-1273
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Mirabel Mariana^ORCID,Eslami Assié,Thibault Constance,Oudard Stéphane,Mousseaux Elie,Wahbi Karim,Fabre Elizabeth,Terrier Benjamin,Marijon Eloi,Villefaillot Aurélie,Fayol Antoine,Dragon-Durey Marie-Agnès,Le Louet Agnès Lillo,Bruno Rosa Maria,Soulat Gilles,Hulot Jean Sébastien

Funder

Fondation pour la Recherche Médicale

Fédération Française de Cardiologie

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00392-024-02462-x.pdf

Reference28 articles.

1. Topalian SL et al (2019) Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non–small cell lung cancer treated with nivolumab. JAMA Oncol 5:1411

2. Haslam A, Prasad V (2019) Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open 2:e192535

3. Cortes J et al (2022) Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N Engl J Med 387:217–226

4. Johnson DB et al (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 375:1749–1755

5. Salem J-E et al (2018) Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol 19:1579–1589

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors;Pharmaceuticals;2024-07-21

3. Sudden cardiac arrest in patients with cancer in the general population: insights from the Paris-SDEC registry;Heart;2024-07-02